Ameritas Investment Partners Inc. Has $1.20 Million Position in Hamilton Lane Inc. $HLNE

Ameritas Investment Partners Inc. cut its stake in shares of Hamilton Lane Inc. (NASDAQ:HLNE) by 32.9% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 8,414 shares of the company’s stock after selling 4,124 shares during the period. Ameritas Investment Partners Inc.’s holdings in Hamilton Lane were worth $1,196,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in HLNE. CWM LLC boosted its stake in shares of Hamilton Lane by 18.2% during the 1st quarter. CWM LLC now owns 611 shares of the company’s stock valued at $91,000 after buying an additional 94 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Hamilton Lane during the first quarter worth $1,454,000. Avantax Advisory Services Inc. boosted its position in Hamilton Lane by 11.2% during the first quarter. Avantax Advisory Services Inc. now owns 8,280 shares of the company’s stock valued at $1,231,000 after purchasing an additional 834 shares during the last quarter. Cetera Investment Advisers boosted its position in Hamilton Lane by 73.1% during the first quarter. Cetera Investment Advisers now owns 4,682 shares of the company’s stock valued at $696,000 after purchasing an additional 1,977 shares during the last quarter. Finally, Assetmark Inc. grew its stake in Hamilton Lane by 2.6% in the first quarter. Assetmark Inc. now owns 10,287 shares of the company’s stock valued at $1,529,000 after purchasing an additional 265 shares in the last quarter. Institutional investors and hedge funds own 97.40% of the company’s stock.

Hamilton Lane Price Performance

Shares of Hamilton Lane stock opened at $122.41 on Friday. Hamilton Lane Inc. has a twelve month low of $111.98 and a twelve month high of $200.79. The company has a debt-to-equity ratio of 0.29, a quick ratio of 4.32 and a current ratio of 4.32. The firm has a market cap of $6.83 billion, a P/E ratio of 23.54 and a beta of 1.23. The firm’s 50-day simple moving average is $126.10 and its 200-day simple moving average is $143.44.

Hamilton Lane (NASDAQ:HLNE) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $1.54 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.46. Hamilton Lane had a net margin of 30.66% and a return on equity of 29.47%. The firm had revenue of $190.88 million during the quarter, compared to analysts’ expectations of $171.86 million. As a group, research analysts expect that Hamilton Lane Inc. will post 4.97 EPS for the current fiscal year.

Hamilton Lane Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Friday, December 19th will be given a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Friday, December 19th. Hamilton Lane’s dividend payout ratio is 39.13%.

Wall Street Analyst Weigh In

HLNE has been the subject of a number of recent research reports. The Goldman Sachs Group raised Hamilton Lane from a “neutral” rating to a “buy” rating and set a $165.00 price target for the company in a research note on Thursday, November 6th. Morgan Stanley cut their price objective on shares of Hamilton Lane from $169.00 to $154.00 and set an “equal weight” rating on the stock in a research report on Tuesday, October 21st. Weiss Ratings downgraded shares of Hamilton Lane from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Saturday, October 25th. BMO Capital Markets started coverage on shares of Hamilton Lane in a research note on Friday, October 3rd. They set an “outperform” rating and a $150.00 price target on the stock. Finally, Zacks Research lowered shares of Hamilton Lane from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 22nd. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $159.29.

Insider Buying and Selling at Hamilton Lane

In related news, CEO Juan Delgado-Moreira acquired 8,000 shares of the business’s stock in a transaction on Friday, November 7th. The stock was bought at an average cost of $130.35 per share, with a total value of $1,042,800.00. Following the completion of the acquisition, the chief executive officer owned 1,314,447 shares in the company, valued at $171,338,166.45. The trade was a 0.61% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder River 5 Ltd French sold 150,000 shares of the business’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $146.51, for a total transaction of $21,976,500.00. Following the completion of the sale, the insider owned 330,015 shares in the company, valued at $48,350,497.65. This represents a 31.25% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 22.21% of the company’s stock.

Hamilton Lane Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.